The US Food and Drug Administration (FDA) has approved two new medications for cancer.

This week, the US Food and Drug Administration (FDA) approved Eisai Inc.'s drug derived from sea sponge for a rare type of soft tissue cancer.

Babies can be born with cancer that developed in the mother’s womb. One such cancer is a disease with a long name: infantile myofibromatosis (IM).

Cancer that either starts in or spreads to the bone can be extremely painful. So can cancers that begin in the muscles or other soft tissue of the body. A relatively new treatment method may bring much needed relief.

After a rigorous battle, Venezuelan president Hugo Chavez has died of cancer. He was 58. Chavez recently returned from Cuba, where he received the fourth and final surgery for cancer described imprecisely as “pelvic cancer.”

The US Food and Drug Administration has approved a medication to treat gastrointestinal stromal tumors (GIST) that can’t be removed with surgery, have spread or no longer respond to existing therapies.

Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.

A cancer you don’t hear about much attacks the tissues that connect digestive organs. These are called GIST, which is easier to say than "gastrointestinal stromal tumors". Scientists have found a drug that helps kicks GIST in the gut.

Cancers that appear in the soft tissues of the body are very rare. In fact, they are seen in only about 5 people out of every 100,000. A recent study looked at the best way to treat this cancer.

Kaposi sarcoma (KS) is a soft-tissue cancer that’s associated with a herpes virus. KS is seen in many people who are HIV positive. The tumors show up as purple, red or brown spots. A new treatment for this condition could be in the works.